These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18519868)

  • 1. To test or not to test: NMO-IgG and optic neuritis.
    Giovannoni G
    Neurology; 2008 Jun; 70(23):2192-3. PubMed ID: 18519868
    [No Abstract]   [Full Text] [Related]  

  • 2. Should most patients with optic neuritis be tested for neuromyelitis optica antibodies and should this affect their treatment?
    Galetta SL; Cornblath WT
    J Neuroophthalmol; 2010 Dec; 30(4):376-8; discussion 378-9. PubMed ID: 21107126
    [No Abstract]   [Full Text] [Related]  

  • 3. NMO-IgG predicts the outcome of recurrent optic neuritis.
    Matiello M; Lennon VA; Jacob A; Pittock SJ; Lucchinetti CF; Wingerchuk DM; Weinshenker BG
    Neurology; 2008 Jun; 70(23):2197-200. PubMed ID: 18434643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromyelitis optica antibodies in patients with severe optic neuritis in China.
    Lai C; Tian G; Takahashi T; Liu W; Yang L; Zhang X
    J Neuroophthalmol; 2011 Mar; 31(1):16-9. PubMed ID: 21150455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
    Hamnik SE; Hacein-Bey L; Biller J; Gruener G; Jay W
    Semin Ophthalmol; 2008; 23(3):191-200. PubMed ID: 18432545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of IgG-NMO autoantibodies on S100Beta protein and disability in relapsing neuromyelitis optica.
    Robinson-Agramonte MA; Gonçalves CA; Portela LV; Saiz-Hinarejos A; Oses JP; Motta LS; Muller AP; Marquez Gonzalez ME; Souza DO
    Neuroimmunomodulation; 2010; 17(3):177-9. PubMed ID: 20134196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis.
    Petzold A; Pittock S; Lennon V; Maggiore C; Weinshenker BG; Plant GT
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):109-11. PubMed ID: 20019228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
    Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
    J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.
    Siuko M; Tienari PJ; Saastamoinen KP; Atula S; Miettinen A; Kivelä T; Setälä K
    Acta Ophthalmol; 2014 Jun; 92(4):387-91. PubMed ID: 23773223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic relapsing inflammatory optic neuropathy (CRION) without detection of IgG-NMO antibodies].
    Pérez-Díaz H; Casado JL; Uclés-Sánchez A; Saiz A
    Neurologia; 2007 Oct; 22(8):553-5. PubMed ID: 18000764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.
    Piccolo L; Woodhall M; Tackley G; Juryńczyk M; Kong Y; Domingos J; Gore R; Vincent A; Waters P; Leite MI; Palace J
    J Neurol; 2016 Feb; 263(2):370-379. PubMed ID: 26668077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen.
    Jarius S; Probst C; Borowski K; Franciotta D; Wildemann B; Stoecker W; Wandinger KP
    J Neurol Sci; 2010 Apr; 291(1-2):52-6. PubMed ID: 20117794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential Optic Neuritis: A Neuromyelitis Optica Spectrum Disorder.
    Alam M; Haq MAU; Iqbal A; Ullah K; Nabi D
    J Coll Physicians Surg Pak; 2019 Apr; 29(4):379-380. PubMed ID: 30925966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
    Misu T; Takahashi T; Nakashima I; Fujihara K; Itoyama Y
    Rinsho Byori; 2009 Mar; 57(3):262-70. PubMed ID: 19363997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMO-IgG in the diagnosis of neuromyelitis optica.
    Jarius S; Franciotta D; Bergamaschi R; Wright H; Littleton E; Palace J; Hohlfeld R; Vincent A
    Neurology; 2007 Mar; 68(13):1076-7. PubMed ID: 17287449
    [No Abstract]   [Full Text] [Related]  

  • 18. Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients.
    Saiz A; Zuliani L; Blanco Y; Tavolato B; Giometto B; Graus F;
    J Neurol; 2007 Sep; 254(9):1233-7. PubMed ID: 17401734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].
    Vaknin-Dembinsky A; Levin N; Raz N; Abramsky O; Karussis D; Brill L; Petrou P; Ovadia H
    Harefuah; 2013 Feb; 152(2):101-5, 122. PubMed ID: 23513502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuromyelitis optica is a frequently seen inflammatory demyelinating disease].
    Asgari N; Skejø HP; Lillevang ST; Stenager E
    Ugeskr Laeger; 2013 May; 175(19):1331-5. PubMed ID: 23663369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.